Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

dti announces nominees for 2008 Science and Technology Awards
2008-10-03

 

At the announcement of the nominees for the 2008 dti Technology Awards were, from the left: Prof. Schalk Louw, Department of Zoology and Entomology, Mr Sipho Zikode, Deputy Director General at the Department of Trade and Industry (dti), Dr Romilla Maharaj, Executive Director: Human and Institutional Capacity Development at the National Research Foundation (NRF), and Mr Ephraim Baloyi, Director: Innovation and Technology at the dti.

Mr Michael Chung, master’s student in Plant Pathology, explaining some of the research conducted in the Centre for Plant Health Management (Cephma).

Prof. Schalk Louw, Department of Zoology and Entomology, and Mr Ephraim Baloyi, Director: Innovation and Technology at the dti in the Cephma laboratory.

   
dti announces nominees for 2008 Science and Technology Awards

The Department of Trade and Industry’s (dti) Deputy Director-General, Mr Sipho Zikode, yesterday announced the nominees for the 2008 dti Technology Awards which will take place on 30 and 31 October in Bloemfontein.

The purpose of these annual awards is to recognise those researchers, private institutions and students who performed well in terms of innovation and technology development, says Mr Ephraim Baloyi, Director: Innovation and Technology at the dti.

The awards are a combination of the Annual Awards of the different dti programmes supporting technology in industry. They are the Technology and Human Resources for Industry Programme (THRIP), administered by the National Research Foundation (NRF), the Support Programme for Industrial Innovation (SPII), administered by the Industrial Development Corporation, and seda Technology Programme (stp), administered by the Small Enterprise Development Agency.

The dti delegation also visited the laboratory of Prof. Schalk Louw of the UFS to view the work of this former dti Technology Awards recipient. Prof. Louw is a member of the UFS Centre for Plant Health Management (Cephma) team that won a 2007 Technology Award for groundbreaking research work on kenaf (a South African commercial fibre crop used, amongst others, in the automotive industry). The research of the Cephma team is supported by the NRF’s THRIP programme.

The awards are hosted in a different province each year to increase awareness around the dti’s technology support for researchers, small enterprises, large industries and business incubators.

Media Release
Issued by: Leonie Bolleurs
Tel: 051 401 2707
Cell: 083 645 5853
3 October 2008

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept